| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Nuechterlein Carole | Latham & Watkins Llp (filing Agent) /fa | 06/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/26/2025 | |
| 4 | Statement of changes in beneficial owner... | Nuechterlein Carole | Latham & Watkins Llp (filing Agent) /fa | 06/26/2025 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Nuechterlein Carole | Latham & Watkins Llp (filing Agent) /fa | 06/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 02/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Nuechterlein Carole | Latham & Watkins Llp (filing Agent) /fa | 02/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 10/27/2023 | |
| 4 | Statement of changes in beneficial owner... | Nuechterlein Carole | Latham & Watkins Llp (filing Agent) /fa | 10/27/2023 | |
| Load More |
SEC Filing Data
